Antiviral therapy improves the survival rate and decreases recurrences and fatalities in liver cancer patients following curative resection: A meta-analysis

por ZHANG, HAO, ZHOU, YUCHEN, YUAN, GUOSHENG, ZHOU, GUANGYAO, YANG, DINGHUA, ZHOU, YUANPING
Publicado 2015

DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway

por Hu, Xiaoyun, Yuan, Guosheng, Li, Qi, Huang, Jing, Cheng, Xiao, Chen, Jinzhang
Publicado 2021

Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis

por Hu, Xiaoyun, Li, Rong, Li, Qi, Zang, Mengya, Yuan, Guosheng, Chen, Jinzhang
Publicado 2022

Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients

por Chen, Jinzhang, Hu, Xiaoyun, Li, Qi, Dai, Wencong, Cheng, Xiao, Huang, Wei, Yu, Wenxuan, Chen, Mian, Guo, Yabing, Yuan, Guosheng
Publicado 2020

Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retro...

por Yuan, Guosheng, Li, Rong, Li, Qi, Hu, Xiaoyun, Ruan, Jian, Fan, Wenzhe, Wang, Junjie, Huang, Wei, Zang, Mengya, Chen, Jinzhang
Publicado 2021

Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement

por Duan, Xiaobing, Anwar, Muhammad Ikram, Xu, Zhanxue, Ma, Ling, Yuan, Guosheng, Chen, Yiyi, Liu, Xi, Xia, Jinyu, Zhou, Yuanping, Li, Yi-Ping
Publicado 2018

Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

por Li, Qi, Cao, Mengran, Yuan, Guosheng, Cheng, Xiao, Zang, Mengya, Chen, Ming, Hu, Xiaoyun, Huang, Jing, Li, Rong, Guo, Yabing, Ruan, Jian, Chen, Jinzhang
Publicado 2022

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients

por Yuan, Guosheng, Song, Yangda, Li, Qi, Hu, Xiaoyun, Zang, Mengya, Dai, Wencong, Cheng, Xiao, Huang, Wei, Yu, Wenxuan, Chen, Mian, Guo, Yabing, Zhang, Qifan, Chen, Jinzhang
Publicado 2021

Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China

por Hu, Chengguang, Yuan, Guosheng, Liu, Junwei, Huang, Huaping, Ren, Yanyu, Li, Yinping, Chen, Xuefu, Li, Wei, Wu, Tao, Deng, Hong, Peng, Yanzhong, Zhang, Yong-Yuan, Zhou, Yuanping
Publicado 2018

Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

por Yuan, Guosheng, Cheng, Xiao, Li, Qi, Zang, Mengya, Huang, Wei, Fan, Wenzhe, Wu, Tao, Ruan, Jian, Dai, Wencong, Yu, Wenxuan, Chen, Mian, Guo, Yabing, Hu, Xiaoyun, Chen, Jinzhang
Publicado 2020

Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysi...

por Yuan, Guosheng, Xie, Fuli, Song, Yangda, Li, Qi, Li, Rong, Hu, Xiaoyun, Zang, Mengya, Cheng, Xiao, Lu, Guanting, Huang, Jing, Fan, Wenzhe, Rong, Xiaoxiang, Sun, Jian, Chen, Jinzhang
Publicado 2022

Development of an Infectious Cell Culture System for Hepatitis C Virus Genotype 6a Clinical Isolate Using a Novel Strategy and Its Sensitivity to Direct-Acting Antivirals

por Chen, Mingxiao, Zheng, Fuxiang, Yuan, Guosheng, Duan, Xiaobing, Rong, Liang, Liu, Junwei, Feng, Shengjun, Wang, Ziting, Wang, Min, Feng, Yetong, Zhou, Qing, Li, Jinqian, Deng, Kai, Li, Chunna, Xia, Jinyu, Rao, Guirong, Zhou, Yuanping, Fu, Yongshui, Li, Yi-Ping
Publicado 2018

Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study

por Fan, Wenzhe, Zhu, Bowen, Yue, Shufan, Zheng, Xinlin, Yuan, Guosheng, Yu, Lei, Huang, Wanchang, Huang, Shugui, Wei, Wenjiang, Li, Fuliang, Huang, Zhen, Tang, Rong, Fan, Huishuang, Li, Zhuoyong, Qiao, Liangliang, Huang, Fuxi, Cheng, Yu, Zhang, Yingqiang, Wu, Yanqin, Zou, Xinhua, Xue, Miao, Wang, Hongyu, Li, Jiaping
Publicado 2022